160 related articles for article (PubMed ID: 34164887)
1. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial.
Messineo L; Carter SG; Taranto-Montemurro L; Chiang A; Vakulin A; Adams RJ; Carberry JC; Eckert DJ
Respirology; 2021 Sep; 26(9):878-886. PubMed ID: 34164887
[TBL] [Abstract][Full Text] [Related]
2. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity.
Messineo L; Eckert DJ; Lim R; Chiang A; Azarbarzin A; Carter SG; Carberry JC
J Physiol; 2020 Oct; 598(20):4681-4692. PubMed ID: 32864734
[TBL] [Abstract][Full Text] [Related]
3. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
4. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
5. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
6. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway.
Corser B; Eves E; Warren-McCormick J; Rucosky G
J Clin Sleep Med; 2023 Jun; 19(6):1035-1042. PubMed ID: 36734173
[TBL] [Abstract][Full Text] [Related]
7. The combination of atomoxetine and oxybutynin for the treatment of obstructive sleep apnea in children with Down syndrome.
Combs D; Edgin J; Hsu CH; Bottrill K; Van Vorce H; Gerken B; Matloff D; La Rue S; Parthasarathy S
J Clin Sleep Med; 2023 Dec; 19(12):2065-2073. PubMed ID: 37555595
[TBL] [Abstract][Full Text] [Related]
8. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
9. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
10. The Combination of Betahistine and Oxybutynin Increases Respiratory Control Sensitivity (Loop Gain) in People with Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial.
Messineo L; Loffler K; Chiang A; Osman A; Taranto-Montemurro L; Eckert DJ
Nat Sci Sleep; 2022; 14():1063-1074. PubMed ID: 35698591
[TBL] [Abstract][Full Text] [Related]
11. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
12. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
[TBL] [Abstract][Full Text] [Related]
13. Randomized Trial on the Effects of High-Dose Zopiclone on OSA Severity, Upper Airway Physiology, and Alertness.
Carter SG; Carberry JC; Grunstein RR; Eckert DJ
Chest; 2020 Jul; 158(1):374-385. PubMed ID: 32197956
[TBL] [Abstract][Full Text] [Related]
14. Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial.
Carter SG; Carberry JC; Cho G; Fisher LP; Rollo CM; Stevens DJ; D'Rozario AL; McKenzie DK; Grunstein RR; Eckert DJ
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29976648
[TBL] [Abstract][Full Text] [Related]
15. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial.
Perger E; Taranto Montemurro L; Rosa D; Vicini S; Marconi M; Zanotti L; Meriggi P; Azarbarzin A; Sands SA; Wellman A; Lombardi C; Parati G
Chest; 2022 Jan; 161(1):237-247. PubMed ID: 34543665
[TBL] [Abstract][Full Text] [Related]
16. The combination of atomoxetine and dronabinol for the treatment of obstructive sleep apnea: a dose-escalating, open-label trial.
Messineo L; Norman D; Ojile J
J Clin Sleep Med; 2023 Jul; 19(7):1183-1190. PubMed ID: 36805833
[TBL] [Abstract][Full Text] [Related]
17. The effects of zolpidem in obstructive sleep apnea - An open-label pilot study.
Carberry JC; Grunstein RR; Eckert DJ
J Sleep Res; 2019 Dec; 28(6):e12853. PubMed ID: 30968498
[TBL] [Abstract][Full Text] [Related]
18. A single dose of noradrenergic/serotonergic reuptake inhibitors combined with an antimuscarinic does not improve obstructive sleep apnoea severity.
Thomson LDJ; Landry SA; Joosten SA; Mann DL; Wong AM; Cheung T; Adam M; Beatty CJ; Hamilton GS; Edwards BA
Physiol Rep; 2022 Aug; 10(16):e15440. PubMed ID: 36029192
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
20. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
